Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188.
2.
KamstrupPRTybjaerg-HansenANordestgaardBG.Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol2013;
61: 1146–1156.
3.
WilleitPKiechlSKronenbergF, et al.
Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol2014;
64: 851–860.
4.
VerbeekRSandhuMSHovinghGK, et al.
Lipoprotein(a) improves cardiovascular risk prediction based on established risk algorithms. J Am Coll Cardiol2017;
69: 1513–1515.
5.
FirmannMMayorVVidalPM, et al.
The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord2008;
8: 6.
6.
BeuretHHauslerNNanchenD, et al. Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland. Eur J Prev Cardiol. Epub ahead of print 23 February 2020. DOI: 10.1177/2047487320906305.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
